Enzymic degradation of a β-lactam antibiotic, ampicillin, in the gut: a novel treatment modality
Authors: Harmoinen, Jaana; Vaali, Kirsi; Koski, Pertti; Syrjänen, Kaisa; Laitinen, Outi; Lindevall, Kai; Westermarck, Elias
Source: Journal of Antimicrobial Chemotherapy, Volume 51, Number 2, February 2003 , pp. 361-365(5)
Publisher: Oxford University Press
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Antibiotics can cause severe alterations in the gut microflora and promote diarrhoea and overgrowth of pathogenic bacteria. The present study investigated the potency of targeted recombinant β-lactamase (TRBL) to degrade a β-lactam antibiotic in the jejunum of fistula-operated beagles. We used different peroral doses of purified β-lactamase (PenP) of Bacillus licheniformis in enteric-coated pellets together with intravenous ampicillin. Serum and jejunal samples were collected for ampicillin and β-lactamase analysis. A dose–response effect of TRBL on ampicillin concentrations in the jejunal samples could be observed. The highest doses applied decreased the jejunal ampicillin concentrations to undetectable levels. In the serum samples, the ampicillin concentrations were not affected by the β-lactamase dose used. Our results indicate that it may be possible to evolve a targeted treatment to degrade β-lactam antibiotics intestinally and, thus, decrease antibiotic-induced adverse effects on the gut microflora.Keywords: β-lactamase, β-lactams, jejunum, microflora
Document Type: Research article
DOI: 10.1093/jac/dkg095
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Click here for Page Help